Evidence map›Paper›PMID 40711366›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025

Novel Synthesis of the Antifungal Cyclic Lipopeptide Iturin A and Its Fluorinated Analog for Structure-Activity Relationship Studies.

Periklis Karamanis, Matthew Kiernan, Jimmy Muldoon, Finn Doyle, Paul Evans, Cormac D Murphy, Marina Rubini

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Periklis KaramanisSchool of Chemistry, University College Dublin, Dublin, Ireland.
Matthew KiernanSchool of Chemistry, University College Dublin, Dublin, Ireland.
Jimmy MuldoonSchool of Chemistry, University College Dublin, Dublin, Ireland.
Finn DoyleSchool of Chemistry, University College Dublin, Dublin, Ireland.
Paul EvansSchool of Chemistry, University College Dublin, Dublin, Ireland.
Cormac D MurphyBiOrbic Bioeconomy SFI Research Centre, University College Dublin, Dublin, Ireland.
Marina RubiniSchool of Chemistry, University College Dublin, Dublin, Ireland.ORCID 0000-0002-3102-2558

Funding

Science Foundation Ireland 16/RC/3889Science Foundation Ireland 18/EPSRC-CDT/3582SFI Research Infrastructure Programme 2019-ref 18/RI/5702
6 · The paper itself

Abstract

The rapid development of antifungal resistance poses a threat to the health and agricultural sectors. Iturin A, a cyclic lipopeptide with pronounced antifungal properties produced by Bacillus sp., holds promise against several pathogens. Here, a novel synthesis of iturin A is presented, which enables access to different analogs for the study of its mode of action. The route includes the enantioselective synthesis of the β-amino fatty acid present in the lipopeptide structure, followed by solid-phase peptide synthesis and on-resin cyclization. This robust synthesis was used to obtain natural iturin A. Furthermore, the synthesis of two analogs is described: an epimer with an inverted stereochemistry of the β-amino fatty acid, which was designed to shed light on the role of this stereocenter on iturin A's bioactivity, and a monofluorinated analog to assess fluorination's impact on bioactivity and as a fluorine NMR probe for mechanistic studies. Antifungal assays against Candida albicans and Fusarium graminearum showed that the epimer of iturin A lost all bioactivity, while the monofluorinated analog retained the bioactivity of the natural compound, thus confirming its potential as an NMR probe.

Indexed as

Antifungal AgentsLipopeptidesPeptides, CyclicCandida albicansCyclizationFusariumHalogenationMicrobial Sensitivity TestsStereoisomerismStructure-Activity RelationshipAntifungal Agentsiturin ALipopeptidesPeptides, Cyclicantifungal agentscyclic lipopeptidesfluorinated peptidesfluorine NMRiturin Apeptide cyclizationpeptides

Identifiers

PMID40711366
PMCPMC12376246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.